Fernandez 1997.

Methods	Allocation concealment: unclear. Blinding: yes. Intention to treat: yes. Methodological score: 17.
Participants	NAIVE HEMODIALYSED PATIENTS WITH CHRONIC HEPATITIS C Arms: 14/9 Excluded: 3/2 Mean age: 44/49 % males: 36/67 % transfusion: 36/67 % drug abuse: 0/0 % cirrhosis: NDA Genotypes: G1 (54/78%), G2,3 (38/22%) Disease duration: 2/2
Interventions	Experimental: Alfa‐2b IFN 1.5 MU TIW x 3 mo; increased to 3 MU TIW x 6 mo if ALT still elevated Control: placebo Follow‐up: 18 mo
Outcomes	‐ biochemical ETR and SR ‐ virologic ETR and SR
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Unclear risk	B ‐ Unclear